Probiodrug AG

Probiodrug AG
Stock Exchange Euronext - Alternext Amsterdam
EPS
EUR0.95
Market Cap
EUR23.41 M
Shares Outstanding
8.19 M
Public Float
4.72 M
Probiodrug AG
Stock Exchange Frankfurt Stock Exchange
EPS
EUR0.94
Market Cap
EUR44.21 M
Shares Outstanding
8.21 M
Public Float
-

Profile

Address
Weinbergweg 22
Halle Sachsen-Anhalt 06120
Germany
Employees -
Website http://www.probiodrug.de
Updated 07/08/2019
Probiodrug AG is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.

Financials

View All

Erich Maximilian Platzer
Chairman-Supervisory Board
Charlotte Lohmann
Member-Supervisory Board